EDGAR Filing Documents for 0001140361-15-001931

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001140361-15-001931

Filing Date

2015-01-15

Accepted

2015-01-15 16:58:02

Documents

Period of Report

2015-01-13

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	doc1.html	4
1	FORM 4	doc1.xml	4	5918
	Complete submission text file	0001140361-15-001931.txt		7316

Mailing Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025

Business Address 1035 O?BRIEN DRIVE, SUITE A MENLO PARK CA 94025 650-272-6269

Avalanche Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AVALANCHE BIOTECHNOLOGIES, INC. 1035 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025

Business Address

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 15530469